# Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma

> **NCT05620693** · NA · RECRUITING · sponsor: **Shenzhen University General Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Advanced Soft-tissue Sarcoma

## Interventions

- **BIOLOGICAL:** NY-ESO-1 TCR-T

## Key facts

- **NCT ID:** NCT05620693
- **Lead sponsor:** Shenzhen University General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-11-11
- **Primary completion:** 2025-12-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05620693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05620693, "Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05620693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*